The Food and Drug Administration (FDA) is developing new guidance intended to help make people fully aware of the abuse or addiction possibilities of the prescriptions they’re taking. Drug Abuse and Dependence Section of Labeling for Human Prescription Drug and Biological Products - Content and Format doesn’t just deal with prescription medications that are scheduled under the Controlled Substances Act (CSA). Medications not scheduled under the CSA that have dependence potential are also addressed.
Are you a worker who is experiencing low back pain? You aren’t alone! A recently published article from NIOSH reports that more than 1 in 4 (26%) working adults experience low back pain.
Some groups of workers have more pain than others. For example, workers in construction occupations are more likely to experience low back pain than those in other occupations. And, workers 45-64 years old have more pain than younger workers.
A new report finds about one in three cancer survivors (34.6%) reported having chronic pain, representing nearly 5.4 million cancer survivors in the United States. The report, appearing as a Research Letter in JAMA Oncology, finds one in six survivors (16%), representing about 2.5 million people in the U.S., reported suffering from high impact chronic pain that restricts daily functioning. Those rates are about double the rates in the general population.
Perhaps you read about the NIOSH study published in late August that found construction workers die of drug overdoses (not while on the job) at a rate six times higher than the general work population. Heroin was the main killer, followed by prescription opioids.
That the opioid crisis is wreaking havoc on individuals’ lives, tearing families apart and straining municipal emergency response resources is well documented. What is getting less attention is the effects opioid use and misuse may have in the workplace – and the role of work-related injuries in making a person susceptible to opioid addiction.
One state’s successful strategies for reducing the number of injured workers at risk for opioid addiction will be shared with workers compensation experts from around the country at the upcoming Workers Compensation Research Institute’s (WCRI) conference in Boston. In 2011, the OBWC found that more than 8,000 injured workers were opioid-dependent for taking the equivalent of at least 60 mg a day of morphine for 60 or more days. By the end of 2017, that number was reduced to 3,315, which meant 4,714 fewer injured workers were at risk for opioid addiction, overdose, and death than in 2011.
Longer-term prescribing of opioids causes substantially longer duration of temporary disability among workers with work-related low back injuries, according to a new study from the Workers Compensation Research Institute (WCRI). Temporary disability is time that workers spend away from work recovering from their work-related injuries.
A national survey conducted by the U.S. Pain Foundation, with support from McNeil Consumer Healthcare, has found that while nearly all consumers (97%) say they feel confident when choosing which over-the-counter (OTC) pain reliever to take, many disregard important safety factors that medical professionals say are critical to selecting which OTC pain reliever is most appropriate for their health profile.
In the United States, neck pain and other injuries to the upper arms and back are the underlying causes of approximately one-third of injury-related lost workdays in manufacturing.
If you have ever experienced persistent neck pain, you know that it can affect every aspect of daily life.